{"id":46774,"date":"2019-11-20T18:02:29","date_gmt":"2019-11-20T16:02:29","guid":{"rendered":"https:\/\/www.csregypt.com\/?p=46774"},"modified":"2019-11-20T19:01:34","modified_gmt":"2019-11-20T17:01:34","slug":"johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period","status":"publish","type":"post","link":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/","title":{"rendered":"Johnson &#038; Johnson new Ebola vaccine targets 50,000 people in 4 months"},"content":{"rendered":"<div style=\"direction: ltr;\">Approximately 23,000 doses of the Ad26.ZEBOV\/MVA-BN-Filo vaccine\u2014manufactured by Johnson &amp; Johnson (J&amp;J)\u2014have arrived in the Democratic Republic of Congo (DRC). Trained immunization teams will initially administer the vaccine in two sites, with four more to be set up in the coming weeks. It will be offered to adults and to children aged one and older according to the study protocol, and initially target 50,000 people over a four-month period.<\/div>\n<div style=\"direction: ltr;\"><\/div>\n<div style=\"direction: ltr;\">Over the past few weeks, preparations to introduce a new Ebola vaccine have been underway in two health districts in DRC&#8217;s capital Goma\u00a0which is a city of two million people. DRC\u2019s Ministry of Health announced that vaccination began on November 14 as part of a large-scale clinical study in areas of the country affected by the\u00a0<a href=\"https:\/\/www.doctorswithoutborders.org\/ebola-outbreak-drc\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.doctorswithoutborders.org\/ebola-outbreak-drc&amp;source=gmail&amp;ust=1574348086715000&amp;usg=AFQjCNHH1QD-imOgqF1-LqsHl0aPeINJ8Q\">ongoing Ebola epidemic<\/a>. The international medical humanitarian organization Doctors Without Borders\/M\u00e9decins Sans Fronti\u00e8res (MSF) is a partner in a consortium of international organizations involved in planning and implementing the study.<\/div>\n<div><\/div>\n<div style=\"direction: ltr;\">The arrival of the new vaccine means that more people who are at risk of contracting\u00a0<a href=\"https:\/\/www.doctorswithoutborders.org\/what-we-do\/medical-issues\/ebola\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.doctorswithoutborders.org\/what-we-do\/medical-issues\/ebola&amp;source=gmail&amp;ust=1574348086715000&amp;usg=AFQjCNHvgcqONkBBLHvb6uF02XH6TfkmEw\">Ebola<\/a>\u00a0can potentially be protected. Additionally, the study will result in more data on this second Ebola vaccine, which could pave the way for another approved tool to fight future Ebola epidemics. Currently, Merck\u2019s rVSV-ZEBOV, which was recently approved in Europe, is the only approved vaccine against Ebola.<\/div>\n<p style=\"direction: ltr;\">MSF will manage the new vaccine\u2019s implementation in collaboration with DRC\u2019s Ministry of Health and the Institut National de Recherche Biomedicale. Additionally, MSF community engagement teams have been meeting with people in Majengo and Kahembe health districts in Goma to share information about the vaccine and answer their questions. These two districts have been identified in collaboration with health authorities as the first to be offered the vaccine.<\/p>\n<p style=\"direction: ltr;\">Vaccination is one of the key tools to protect people from the Ebola virus. Merck\u2019s rVSV-ZEBOV vaccine\u2014the vaccine currently being used most widely in DRC\u2014has been proven to be effective and has become a valuable resource in the fight against the epidemic. The introduction of a second vaccine is not meant to replace the rVSV vaccine, but to complement it and hopefully provide us with an additional tool in the fight against future Ebola outbreaks. As this is the tenth outbreak of Ebola in DRC, it makes sense to work towards having another vaccine option introduced into the country.<\/p>\n<p style=\"direction: ltr;\">The vaccine was endorsed in the interim recommendations by WHO\u2019s Strategic Advisory Group of Experts (SAGE) on immunization in May of 2019. It was chosen because it has the most potential among other candidate vaccines. Also because it had already passed phase I and II clinical trials, with over 6,000 human volunteers participating. These studies showed that the vaccine has an excellent safety profile.<\/p>\n<p style=\"direction: ltr;\">\n","protected":false},"excerpt":{"rendered":"<p>Approximately 23,000 doses of the Ad26.ZEBOV\/MVA-BN-Filo vaccine\u2014manufactured by Johnson &amp; Johnson (J&amp;J)\u2014have arrived in the Democratic Republic of Congo (DRC). Trained immunization teams will initially administer the vaccine in two sites, with four more to be set up in the coming weeks. It will be offered to adults and to children aged one and older [&hellip;]<\/p>\n","protected":false},"author":410,"featured_media":46804,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6038,6261,6031,984,6030],"tags":[6430,7481,6402,6251],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Johnson &amp; Johnson new Ebola vaccine targets 50,000 people in 4 months - Csr Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson new Ebola vaccine targets 50,000 people in 4 months - Csr Egypt\" \/>\n<meta property=\"og:description\" content=\"Approximately 23,000 doses of the Ad26.ZEBOV\/MVA-BN-Filo vaccine\u2014manufactured by Johnson &amp; Johnson (J&amp;J)\u2014have arrived in the Democratic Republic of Congo (DRC). Trained immunization teams will initially administer the vaccine in two sites, with four more to be set up in the coming weeks. It will be offered to adults and to children aged one and older [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/\" \/>\n<meta property=\"og:site_name\" content=\"Csr Egypt\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/csregypt\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-20T16:02:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-20T17:01:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"980\" \/>\n\t<meta property=\"og:image:height\" content=\"551\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marwa Zein\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@egyptcsrforum\" \/>\n<meta name=\"twitter:site\" content=\"@egyptcsrforum\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marwa Zein\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/\"},\"author\":{\"name\":\"Marwa Zein\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec\"},\"headline\":\"Johnson &#038; Johnson new Ebola vaccine targets 50,000 people in 4 months\",\"datePublished\":\"2019-11-20T16:02:29+00:00\",\"dateModified\":\"2019-11-20T17:01:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/\"},\"wordCount\":473,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/csregypt.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg\",\"keywords\":[\"#Health\",\"#Johanson\",\"#SDGs\",\"csr\"],\"articleSection\":[\"contribute to solution\",\"CSR\",\"health\",\"news\",\"Sustainable Development\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/\",\"url\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/\",\"name\":\"Johnson & Johnson new Ebola vaccine targets 50,000 people in 4 months - Csr Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/csregypt.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg\",\"datePublished\":\"2019-11-20T16:02:29+00:00\",\"dateModified\":\"2019-11-20T17:01:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#primaryimage\",\"url\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg\",\"contentUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg\",\"width\":980,\"height\":551},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/csregypt.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &#038; Johnson new Ebola vaccine targets 50,000 people in 4 months\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/csregypt.com\/#website\",\"url\":\"https:\/\/csregypt.com\/\",\"name\":\"\u0633\u064a \u0625\u0633 \u0622\u0631 \u0645\u0635\u0631\",\"description\":\"The first portal for CSR in Egypt and Middle East\",\"publisher\":{\"@id\":\"https:\/\/csregypt.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/csregypt.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/csregypt.com\/#organization\",\"name\":\"CSR\",\"url\":\"https:\/\/csregypt.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png\",\"contentUrl\":\"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png\",\"width\":1080,\"height\":1080,\"caption\":\"CSR\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/csregypt\/\",\"https:\/\/x.com\/egyptcsrforum\",\"https:\/\/www.instagram.com\/csr.egypt\/\",\"https:\/\/www.linkedin.com\/in\/csr-egypt-43381ab5\/\",\"https:\/\/www.pinterest.com.au\/csregypt\/\",\"https:\/\/www.youtube.com\/channel\/UCh21PZpnBj2yjj2PeclXz1g\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec\",\"name\":\"Marwa Zein\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g\",\"caption\":\"Marwa Zein\"},\"sameAs\":[\"http:\/\/marwazein1982@gmail.com\"],\"url\":\"https:\/\/csregypt.com\/en\/author\/marwa-zein\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson & Johnson new Ebola vaccine targets 50,000 people in 4 months - Csr Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/","og_locale":"en_US","og_type":"article","og_title":"Johnson & Johnson new Ebola vaccine targets 50,000 people in 4 months - Csr Egypt","og_description":"Approximately 23,000 doses of the Ad26.ZEBOV\/MVA-BN-Filo vaccine\u2014manufactured by Johnson &amp; Johnson (J&amp;J)\u2014have arrived in the Democratic Republic of Congo (DRC). Trained immunization teams will initially administer the vaccine in two sites, with four more to be set up in the coming weeks. It will be offered to adults and to children aged one and older [&hellip;]","og_url":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/","og_site_name":"Csr Egypt","article_publisher":"https:\/\/www.facebook.com\/csregypt\/","article_published_time":"2019-11-20T16:02:29+00:00","article_modified_time":"2019-11-20T17:01:34+00:00","og_image":[{"width":980,"height":551,"url":"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg","type":"image\/jpeg"}],"author":"Marwa Zein","twitter_card":"summary_large_image","twitter_creator":"@egyptcsrforum","twitter_site":"@egyptcsrforum","twitter_misc":{"Written by":"Marwa Zein","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#article","isPartOf":{"@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/"},"author":{"name":"Marwa Zein","@id":"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec"},"headline":"Johnson &#038; Johnson new Ebola vaccine targets 50,000 people in 4 months","datePublished":"2019-11-20T16:02:29+00:00","dateModified":"2019-11-20T17:01:34+00:00","mainEntityOfPage":{"@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/"},"wordCount":473,"commentCount":0,"publisher":{"@id":"https:\/\/csregypt.com\/#organization"},"image":{"@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#primaryimage"},"thumbnailUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg","keywords":["#Health","#Johanson","#SDGs","csr"],"articleSection":["contribute to solution","CSR","health","news","Sustainable Development"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/","url":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/","name":"Johnson & Johnson new Ebola vaccine targets 50,000 people in 4 months - Csr Egypt","isPartOf":{"@id":"https:\/\/csregypt.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#primaryimage"},"image":{"@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#primaryimage"},"thumbnailUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg","datePublished":"2019-11-20T16:02:29+00:00","dateModified":"2019-11-20T17:01:34+00:00","breadcrumb":{"@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#primaryimage","url":"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg","contentUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg","width":980,"height":551},{"@type":"BreadcrumbList","@id":"https:\/\/csregypt.com\/en\/johnson-johnson-new-ebola-vaccine-initially-target-50000-people-over-four-month-period\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/csregypt.com\/"},{"@type":"ListItem","position":2,"name":"Johnson &#038; Johnson new Ebola vaccine targets 50,000 people in 4 months"}]},{"@type":"WebSite","@id":"https:\/\/csregypt.com\/#website","url":"https:\/\/csregypt.com\/","name":"\u0633\u064a \u0625\u0633 \u0622\u0631 \u0645\u0635\u0631","description":"The first portal for CSR in Egypt and Middle East","publisher":{"@id":"https:\/\/csregypt.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/csregypt.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/csregypt.com\/#organization","name":"CSR","url":"https:\/\/csregypt.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png","contentUrl":"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png","width":1080,"height":1080,"caption":"CSR"},"image":{"@id":"https:\/\/csregypt.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/csregypt\/","https:\/\/x.com\/egyptcsrforum","https:\/\/www.instagram.com\/csr.egypt\/","https:\/\/www.linkedin.com\/in\/csr-egypt-43381ab5\/","https:\/\/www.pinterest.com.au\/csregypt\/","https:\/\/www.youtube.com\/channel\/UCh21PZpnBj2yjj2PeclXz1g"]},{"@type":"Person","@id":"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec","name":"Marwa Zein","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g","caption":"Marwa Zein"},"sameAs":["http:\/\/marwazein1982@gmail.com"],"url":"https:\/\/csregypt.com\/en\/author\/marwa-zein\/"}]}},"jetpack_featured_media_url":"https:\/\/csregypt.com\/wp-content\/uploads\/2019\/11\/congo_11.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/46774"}],"collection":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/users\/410"}],"replies":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/comments?post=46774"}],"version-history":[{"count":3,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/46774\/revisions"}],"predecessor-version":[{"id":46826,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/46774\/revisions\/46826"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/media\/46804"}],"wp:attachment":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/media?parent=46774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/categories?post=46774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/tags?post=46774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}